BioCentury | Jan 13, 2003
Company News

Deltagen admet news

...DGEN markets its DeltaBase and DeltaOne target validation services in metabolism and inflammation, and provides XenoPharm...
BioCentury | Dec 17, 2001
Company News

Sequenom management update

...of finance from controller. Hired: Jay Lichter as EVP of business development, formerly CEO of XenoPharm Inc. WIR...
BioCentury | Aug 27, 2001
Company News

XenoPharm, Bristol-Myers deal

...test an undisclosed number of BMY compounds for their induction of drug metabolism enzyme expression. XenoPharm...
...of compounds' abilities to induce expression of liver and intestinal genes, including the CYP3A4 gene. XenoPharm Inc....
BioCentury | Aug 21, 2001
Company News

XenoPharm, BMY profiling deal

...an undisclosed number of Bristol-Myers (BMY) compounds for their induction of drug metabolism enzyme expression. XenoPharm...
BioCentury | Jul 23, 2001
Company News

XenoPharm management update

XenoPharm Inc., San Diego, Calif. Business: ADMET, Genomics Hired: Jay Lichter as president, CEO and a director, formerly VP and chief business officer at 454 Corp. ; and William Schrader as VP of research and...
BioCentury | Jul 11, 2001
Company News

XenoPharm appoints CEO

...formed company XenoPharm (San Diego, Calif.). William Schrader was appointed VP of research and CSO. XenoPharm...
Items per page:
1 - 6 of 6
BioCentury | Jan 13, 2003
Company News

Deltagen admet news

...DGEN markets its DeltaBase and DeltaOne target validation services in metabolism and inflammation, and provides XenoPharm...
BioCentury | Dec 17, 2001
Company News

Sequenom management update

...of finance from controller. Hired: Jay Lichter as EVP of business development, formerly CEO of XenoPharm Inc. WIR...
BioCentury | Aug 27, 2001
Company News

XenoPharm, Bristol-Myers deal

...test an undisclosed number of BMY compounds for their induction of drug metabolism enzyme expression. XenoPharm...
...of compounds' abilities to induce expression of liver and intestinal genes, including the CYP3A4 gene. XenoPharm Inc....
BioCentury | Aug 21, 2001
Company News

XenoPharm, BMY profiling deal

...an undisclosed number of Bristol-Myers (BMY) compounds for their induction of drug metabolism enzyme expression. XenoPharm...
BioCentury | Jul 23, 2001
Company News

XenoPharm management update

XenoPharm Inc., San Diego, Calif. Business: ADMET, Genomics Hired: Jay Lichter as president, CEO and a director, formerly VP and chief business officer at 454 Corp. ; and William Schrader as VP of research and...
BioCentury | Jul 11, 2001
Company News

XenoPharm appoints CEO

...formed company XenoPharm (San Diego, Calif.). William Schrader was appointed VP of research and CSO. XenoPharm...
Items per page:
1 - 6 of 6